Found: 41
Select item for more details and to access through your institution.
Editorial: REVEALing the Score.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Hematologic Disorders and Pulmonary Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2021, v. 20, n. 3, p. 80, doi. 10.21693/1933-088X-20.3.80
- By:
- Publication type:
- Article
Guest Editor's Memo.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Risk Stratification—What's My Risk? A Practitioner's Tool.
- Published in:
- Advances in Pulmonary Hypertension, 2019, v. 18, n. 3, p. 84, doi. 10.21693/1933-088X-18.3.84
- By:
- Publication type:
- Article
Future Therapies in PAH: Update on the New Landscape and Drugs in the Pipeline.
- Published in:
- Advances in Pulmonary Hypertension, 2014, v. 13, n. 2, p. 76, doi. 10.21693/1933-088x-13.2.76
- By:
- Publication type:
- Article
Pulmonary Artery Filling Defects: Are They All the Same?
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.
- Published in:
- Vascular Health & Risk Management, 2008, v. 4, n. 5, p. 943
- By:
- Publication type:
- Article
Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 5, p. 581, doi. 10.1164/rccm.202405-0914SO
- By:
- Publication type:
- Article
An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated With Pulmonary Arterial Hypertension in Men.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2016, v. 193, n. 10, p. E1, doi. 10.1164/rccm.201509-1785oc
- By:
- Publication type:
- Article
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pulmoner arter hipertansiyonunun güncel tedavi algoritması.
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2014, v. 42, n. Supp 1, p. 91
- By:
- Publication type:
- Article
Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signalling.
- Published in:
- Cardiovascular Research, 2018, v. 114, n. 1, p. 65, doi. 10.1093/cvr/cvx198
- By:
- Publication type:
- Article
Synergistic Effects of ANP and Sildenafil on cGMP Levels and Amelioration of Acute Hypoxic Pulmonary Hypertension.
- Published in:
- Experimental Biology & Medicine, 2004, v. 229, n. 9, p. 920, doi. 10.1177/153537020422900908
- By:
- Publication type:
- Article
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 3, p. 489, doi. 10.1002/acr.22121
- By:
- Publication type:
- Article
Practical management of riociguat in patients with pulmonary arterial hypertension.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2019, v. 13, p. 1, doi. 10.1177/1753466619868938
- By:
- Publication type:
- Article
Practical management of riociguat in patients with pulmonary arterial hypertension.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2019, v. 13, p. N.PAG, doi. 10.1177/1753466619868938
- By:
- Publication type:
- Article
Glycolysis regulated transglutaminase 2 activation in cardiopulmonary fibrogenic remodeling.
- Published in:
- FASEB Journal, 2020, v. 34, n. 1, p. 930, doi. 10.1096/fj.201902155R
- By:
- Publication type:
- Article
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 166, p. 1, doi. 10.1183/16000617.0061-2022
- By:
- Publication type:
- Article
Inhaled Therapies for Pulmonary Hypertension... includes discussion by Willson, Hill, MacIntyre, Berlinski, DiBlasi, Restrepo, Hess.
- Published in:
- Respiratory Care, 2015, v. 60, n. 6, p. 794, doi. 10.4187/respcare.03927
- By:
- Publication type:
- Article
Postoperative Pulmonary Hypertension: Etiology and Treatment of a Dangerous Complication.
- Published in:
- Respiratory Care, 2009, v. 54, n. 7, p. 958, doi. 10.4187/002013209793800439
- By:
- Publication type:
- Article
Lung-specific interleukin 6 mediated transglutaminase 2 activation and cardiopulmonary fibrogenesis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1371706
- By:
- Publication type:
- Article
Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies.
- Published in:
- Pulmonary Circulation, 2024, v. 14, n. 2, p. 1, doi. 10.1002/pul2.12386
- By:
- Publication type:
- Article
The heart of the matter: Right heart imaging indicators for treatment escalation in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2023, v. 13, n. 2, p. 1, doi. 10.1002/pul2.12240
- By:
- Publication type:
- Article
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12119
- By:
- Publication type:
- Article
Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 3, p. 1, doi. 10.1177/20458940211025240
- By:
- Publication type:
- Article
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020963836
- By:
- Publication type:
- Article
Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 3, p. 1, doi. 10.1177/2045894020942121
- By:
- Publication type:
- Article
The prognostic significance of pulmonary arterial capacitance in pulmonary arterial hypertension: single-center experience.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 608, doi. 10.1086/688900
- By:
- Publication type:
- Article
Bridging the science into practice.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 498, doi. 10.1086/688489
- By:
- Publication type:
- Article
Plasma 12- and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 2, p. 224, doi. 10.1086/686311
- By:
- Publication type:
- Article
An international physician survey of chronic thromboembolic pulmonary hypertension management.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 472, doi. 10.1086/688084
- By:
- Publication type:
- Article
An international physician survey of pulmonary arterial hypertension management.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 3, p. 338, doi. 10.1086/688058
- By:
- Publication type:
- Article
Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.
- Published in:
- Pulmonary Circulation, 2015, v. 5, n. 3, p. 435, doi. 10.1086/682230
- By:
- Publication type:
- Article
Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2014, v. 4, n. 3, p. 456, doi. 10.1086/677360
- By:
- Publication type:
- Article
Differences between basal lung levels of select eicosanoids in rat and mouse.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 1, p. 82, doi. 10.4103/2045-8932.109918
- By:
- Publication type:
- Article
Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 1, p. 68, doi. 10.4103/2045-8932.109916
- By:
- Publication type:
- Article